(InSilico Medicine, Inc.) Insilico Medicine has formed a collaboration with GSK to to explore how Insilico's AI capability can enhance its drug discovery process. The collaboration has been established following the successful completion by Insilico of a series of pilot challenges. As a first stage of the collaboration, GSK will evaluate Insilico's technology in the identification of novel biological targets and pathways of interest to GSK.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2vIO6QC
No comments:
Post a Comment